MedReleaf, the medical marijuana giant, has reached yet another milestone. The medical marijuana producer, traded under the TSX ticker LEAF, has completed its first international export. This first ever shipment of cannabis oil to the nation of Brazil represents a landmark achievement for not only MedReleaf, but for the progress of the Canadian cannabis industry and the nation as a whole. The completion of this first international shipment of cannabis oil squarely puts the company on the forefront of what is now a global medical marijuana industry.
MedReleaf’s export of cannabis oil was for a very specific purpose; To treat a child with a rare and debilitating genetic disorder. Sofia Langenbach suffered from severe epileptic seizures for nearly two and a half years before being diagnosed with the rare CDKL5 disorder, which was only first identified in 2004. Stemming from a mutation of the CDKL5 gene, it is extremely rare, hard to diagnose and results in neurological problems and seizures, mainly in girls. The condition was crippling, not only for Sofia, but for her mother, Margarette de Santos Brito.
Margarette did what any mother would do for their child. When doctors and medicines couldn’t prevent Sofia’s suffering, she took a step that many parents are forced to take. The anti-convulsive drugs that Sofia was forced to take were only partially effective and came with an unacceptable list of side effects. Margarette needed a better alternative. She made the decision to try what other parents had already found success in; cannabis oil. She risked being jailed by turning to the illicit substance to alleviate the symptoms her daughter’s condition. After discussing the treatment with other parents of children suffering from CDKL5, she decided to risk being jailed and had cannabis oil delivered to her home.
Margarette’s personal experience brought her all the way to Brazil’s court system where she fought for the right to grow her own supply of medical cannabis at home and won. Since then she has gone on to make the fight for patients’ cannabis rights in Brazil and is currently the president of APEPI, the first and largest patients advocacy group in Brazil. Unlike the first shipment of cannabis oil that Margarette accepted for her daughter some years ago, MedReleaf’s cannabis oil was delivered under the guidance of ANVISA, Brazil’s National Health Surveillance Agency.
“We are proud that Ms. Santos and ANVISA, have put their faith in MedReleaf.” stated MedReleaf’s CEO Neil Closner. Closner went on to say, “This is an important step in achieving MedReleaf’s goals of ensuring that patients in need around the world receive the highest quality cannabis-based pharmaceutical products available, and in realizing our long-term growth plans.”
MedReleaf has shown the world once again that it is committed to becoming the medical grade standard for cannabis products not only in the Canada, but in a truly global medical marijuana market. The acceptance of MedReleaf’s cannabis oil by the Brazilian government also shows the level of trust that the nation has put into MedReleaf. This trust demonstrates not only the quality of MedReleaf’s cannabis oil but their ability to navigate the rough seas of international trade. MedReleaf’s delivery of cannabis oil for Sofia is just the first of many yet to come as the company continues to position itself as the leader in the global cannabis market.
Cory Hughes is a former police officer turned cannabis cultivator and writer. After years of being on the wrong side of the law, Cory decided to hang up his badge and gun and move into an industry that truly has the potential of bringing people together. He has been an active part of the Colorado cannabis culture and has worked as a horticulturist in dozens of licensed grow operations. Cory now looks to share his knowledge of cultivation and horticulture with the world.